Literature DB >> 3283924

An in vivo model for evaluation of the postantibiotic effect.

I Odenholt1, S E Holm, O Cars.   

Abstract

A new experimental model to evaluate the postantibiotic effect (PAE) in vivo was developed using subcutaneously implanted tissue cages in rabbits with normal host defence mechanisms. The rabbits received benzylpenicillin i.v. in a dose giving a free penicillin concentration of 10 X MIC in the tissue cage fluid (TCF). A log-phase suspension of group A streptococci was injected into the tissue cages exposing them to penicillin in vivo. After 2 h bacterial samples were withdrawn, treated with penicillinase and transferred to 2 tissue cages in untreated rabbits. Simultaneously, unexposed streptococci were implanted in 2 other cages in the same animals. By repeated sampling of TCF, growth curves of the streptococci exposed to penicillin and the controls could be compared and a PAE of 1.6-2.4 h demonstrated. The PAE was of the same magnitude as that found in vitro. The model has several advantages for the demonstration of PAE in vivo: repeated samplings are easy to perform percutaneously, the effect of subinhibitory antibiotic concentrations are avoided, interindividual variations are eliminated since each animal is its own control, and the experiments can be performed in animals with undisturbed host defence mechanisms.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3283924     DOI: 10.3109/00365548809117224

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  9 in total

1.  Selection of resistant Streptococcus pneumoniae during penicillin treatment in vitro and in three animal models.

Authors:  Jenny Dahl Knudsen; Inga Odenholt; Helga Erlendsdottir; Magnus Gottfredsson; Otto Cars; Niels Frimodt-Møller; Frank Espersen; Karl G Kristinsson; Sigurdur Gudmundsson
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

2.  Pharmacodynamic effects of sub-MICs of benzylpenicillin against Streptococcus pyogenes in a newly developed in vitro kinetic model.

Authors:  E Löwdin; I Odenholt; S Bengtsson; O Cars
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

3.  Variation in postantibiotic effect of clindamycin against clinical isolates of Staphylococcus aureus and implications for dosing of patients with osteomyelitis.

Authors:  I B Xue; P G Davey; G Phillips
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

4.  Postantibiotic and bactericidal effect of imipenem against Pseudomonas aeruginosa.

Authors:  I Odenholt; B Isaksson; L Nilsson; O Cars
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-02       Impact factor: 3.267

Review 5.  Considerations in dosage selection for third generation cephalosporins.

Authors:  J H Yuk-Choi; C H Nightingale; T W Williams
Journal:  Clin Pharmacokinet       Date:  1992-02       Impact factor: 6.447

6.  Penicillin pharmacodynamics in four experimental pneumococcal infection models.

Authors:  H Erlendsdottir; J D Knudsen; I Odenholt; O Cars; F Espersen; N Frimodt-Møller; K Fuursted; K G Kristinsson; S Gudmundsson
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

7.  Postantibiotic effects of imipenem, norfloxacin, and amikacin in vitro and in vivo.

Authors:  J Renneberg; M Walder
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

Review 8.  Impact of dosage schedule of antibiotics on the treatment of serious infections.

Authors:  I A Bakker-Woudenberg; R Roosendaal
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

9.  Correlation of tobramycin-induced inhibition of protein synthesis with postantibiotic effect in Escherichia coli.

Authors:  S Barmada; S Kohlhepp; J Leggett; R Dworkin; D Gilbert
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.